St. Francis has been recognized nationally for its leadership in clinical excellence and research integrity, earning a Tier 1 Scholarship.
Successfully Closes $12M Public Offering, Strengthens Balance Sheet and Supports Anticipated U.S. Launch- Recent Peer-Reviewed Publication ...
Heart failure is a leading cause of hospitalization and long-term disability, with many individuals progressing from subclinical disease to overt symptoms ...
Calcified nodules (CNs) represent a high-risk coronary lesion phenotype associated with target lesion revascularization (TLR). Although rotational atherectomy (RA) is an established treatment for ...
SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Insight Lifetech, a portfolio company of Qiming Venture Partners and a leading Chinese innovative medical device manfaucturer, successfully listed on the ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--SUPERWISE®, a leader in enterprise AI governance and observability, today announced a strategic partnership with NuevoSono, the company is reinventing intravascular ...
Integrating secure AI into advanced intravascular imaging to support precise coronary lesion assessment and improved clinical outcomes SUPERWISE®, a leader in enterprise AI governance and ...
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has entered into an agreement to acquire SpectraWAVE, Inc., an innovator in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results